# Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer

> **NCT03773055** · PHASE2 · TERMINATED · sponsor: **Nobelpharma** · enrollment: 7 (actual)

## Conditions studied

- Neuropathic Pain in Cancer

## Interventions

- **DRUG:** NPC-06

## Key facts

- **NCT ID:** NCT03773055
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-03
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2020-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03773055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03773055, "Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03773055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*